Subtopic Deep Dive

← Genetics, Aging, and Longevity in Model Organisms

Proteostasis Decline in Aging
Research Guide

What is Proteostasis Decline in Aging?

Proteostasis decline in aging refers to the age-related collapse of protein homeostasis networks, including chaperones, proteasome, and autophagy, leading to protein aggregation and cellular dysfunction in model organisms.

This subtopic examines proteostasis loss as a hallmark of aging, characterized by impaired protein folding, degradation, and clearance mechanisms. Key studies in C. elegans demonstrate widespread protein aggregation during aging (David et al., 2010, 639 citations; Ben-Zvi et al., 2009, 659 citations). Over 10 foundational and recent papers, including Labbadia and Morimoto (2015, 1430 citations), detail proteostasis regulators that extend lifespan.

Curated Papers

Key Challenges

Why It Matters

Proteostasis decline drives protein misfolding diseases like Alzheimer's, with restoration strategies extending lifespan in C. elegans (Labbadia and Morimoto, 2015). Interventions targeting chaperone networks ameliorate age-associated hallmarks in vivo (Ocampo et al., 2016). Research identifies FoxO-regulated autophagy and ubiquitin-proteasome systems as therapeutic targets for muscle atrophy and aging (Milan et al., 2015). These findings link proteostasis to healthy aging interventions (Campisi et al., 2019).

Key Research Challenges

Quantifying Proteostasis Collapse Timing

Determining when proteostasis failure initiates during aging remains unresolved, as shown by folding sensor monitoring in C. elegans (Ben-Zvi et al., 2009). Studies reveal early aggregation events but lack precise temporal models across tissues. Integrating multi-omics data is needed for accurate timelines (Taylor and Dillin, 2011).

Chaperone Network Dysregulation

Age-induced shifts in chaperone subnetworks fail to protect against proteotoxic stress in neurodegenerative contexts (Brehme et al., 2014). Balancing inducible versus constitutive chaperones challenges therapeutic design (Morimoto, 2008). Model organisms show tissue-specific declines requiring targeted interventions.

Translating Findings to Longevity

Identifying proteostasis regulators that extend lifespan faces hurdles in scaling from C. elegans to mammals (David et al., 2010). Autophagy and proteasome coordination declines variably across species (Milan et al., 2015). Clinical translation demands biomarkers for proteostasis restoration (Labbadia and Morimoto, 2015).

Essential Papers

The integrated stress response

Karolina Pakos‐Zebrucka, Izabela Koryga, Katarzyna Mnich et al. · 2016 · EMBO Reports · 2.5K citations

The Biology of Proteostasis in Aging and Disease

Johnathan Labbadia, Richard I. Morimoto · 2015 · Annual Review of Biochemistry · 1.4K citations

Loss of protein homeostasis (proteostasis) is a common feature of aging and disease that is characterized by the appearance of nonnative protein aggregates in various tissues. Protein aggregation i...

From discoveries in ageing research to therapeutics for healthy ageing

Judith Campisi, Pankaj Kapahi, Gordon J. Lithgow et al. · 2019 · Nature · 1.3K citations

Aging and aging-related diseases: from molecular mechanisms to interventions and treatments

Jun Guo, Xiuqing Huang, Lin Dou et al. · 2022 · Signal Transduction and Targeted Therapy · 1.3K citations

Abstract Aging is a gradual and irreversible pathophysiological process. It presents with declines in tissue and cell functions and significant increases in the risks of various aging-related disea...

Senescence and aging: Causes, consequences, and therapeutic avenues

Domhnall McHugh, Jesús Gil · 2017 · The Journal of Cell Biology · 1.2K citations

Aging is the major risk factor for cancer, cardiovascular disease, diabetes, and neurodegenerative disorders. Although we are far from understanding the biological basis of aging, research suggests...

The Continuum of Aging and Age-Related Diseases: Common Mechanisms but Different Rates

Claudio Franceschi, Paolo Garagnani, Cristina Morsiani et al. · 2018 · Frontiers in Medicine · 935 citations

Geroscience, the new interdisciplinary field that aims to understand the relationship between aging and chronic age-related diseases (ARDs) and geriatric syndromes (GSs), is based on epidemiologica...

In Vivo Amelioration of Age-Associated Hallmarks by Partial Reprogramming

Alejandro Ocampo, Pradeep Reddy, Paloma Martínez‐Redondo et al. · 2016 · Cell · 903 citations

Reading Guide

Foundational Papers

Start with Morimoto (2008) for chaperone networks in proteotoxic stress, then Ben-Zvi et al. (2009) and David et al. (2010) for C. elegans aggregation evidence, as they establish proteostasis collapse as an early aging event.

Recent Advances

Study Labbadia and Morimoto (2015) for proteostasis biology overview, Ocampo et al. (2016) for reprogramming interventions, and Milan et al. (2015) for FoxO-regulated degradation systems.

Core Methods

Core techniques: proteomics for aggregates (David et al., 2010), folding sensors (Ben-Zvi et al., 2009), chaperone subnetwork analysis (Brehme et al., 2014), and in vivo partial reprogramming (Ocampo et al., 2016).

How PapersFlow Helps You Research Proteostasis Decline in Aging

Discover & Search

PapersFlow's Research Agent uses searchPapers and citationGraph to map proteostasis decline literature, starting from Labbadia and Morimoto (2015) to reveal 1430-cited connections to Morimoto (2008). exaSearch uncovers C. elegans-specific regulators, while findSimilarPapers expands to Ben-Zvi et al. (2009) for aggregation studies.

Analyze & Verify

Analysis Agent employs readPaperContent on David et al. (2010) to extract proteomics data on protein aggregates, then runPythonAnalysis with pandas to quantify aggregation rates across aging stages. verifyResponse via CoVe cross-checks claims against Milan et al. (2015) for FoxO-autophagy links, with GRADE scoring evidence strength for chaperone interventions.

Synthesize & Write

Synthesis Agent detects gaps in translating C. elegans proteostasis findings to mammals (Taylor and Dillin, 2011), flagging contradictions in chaperone efficacy. Writing Agent uses latexEditText and latexSyncCitations to draft reviews citing 10+ papers, with latexCompile generating figures and exportMermaid diagramming proteostasis networks.

Use Cases

"Analyze protein aggregation proteomics data from C. elegans aging papers."

Research Agent → searchPapers('C. elegans proteostasis aggregation') → Analysis Agent → readPaperContent(David et al. 2010) → runPythonAnalysis(pandas on aggregate counts, matplotlib aging curves) → researcher gets CSV of quantified aggregates by age.

"Draft LaTeX review on chaperone networks in proteostasis decline."

Synthesis Agent → gap detection(Labbadia and Morimoto 2015) → Writing Agent → latexEditText(structured sections) → latexSyncCitations(10 papers) → latexCompile → researcher gets compiled PDF with proteostasis diagrams.

"Find GitHub code for proteostasis simulations in model organisms."

Research Agent → paperExtractUrls(Brehme et al. 2014) → paperFindGithubRepo → githubRepoInspect → researcher gets inspected code for chaperone network models with runPythonAnalysis verification.

Automated Workflows

Deep Research workflow conducts systematic reviews of 50+ proteostasis papers, chaining citationGraph from Morimoto (2008) to recent interventions (Ocampo et al., 2016) for structured reports on lifespan extension. DeepScan applies 7-step analysis with CoVe checkpoints to verify aggregation timelines in Ben-Zvi et al. (2009). Theorizer generates hypotheses on FoxO-proteasome links from Milan et al. (2015) literature.

Try Doxa for Proteostasis Decline in Aging Research

Frequently Asked Questions

What defines proteostasis decline in aging?

Proteostasis decline is the age-related failure of protein homeostasis networks, marked by chaperone dysfunction, proteasome impairment, and autophagy collapse, leading to aggregates in model organisms like C. elegans (Labbadia and Morimoto, 2015).

What methods study proteostasis in aging?

Methods include proteomics for aggregation profiling (David et al., 2010), folding sensors in C. elegans (Ben-Zvi et al., 2009), and chaperone network mapping (Brehme et al., 2014).

What are key papers on proteostasis decline?

Foundational works: Morimoto (2008, 868 citations), Ben-Zvi et al. (2009, 659 citations), David et al. (2010, 639 citations). Recent: Labbadia and Morimoto (2015, 1430 citations), Ocampo et al. (2016).

What open problems exist in proteostasis aging research?

Challenges include timing of collapse onset (Taylor and Dillin, 2011), tissue-specific interventions, and mammal translation from C. elegans models (Campisi et al., 2019).